510 (K) Summary: C0Ozt
510 (K) Summary: C0Ozt
510 (K) Summary: C0Ozt
c0ozT¼
510(k) Summary
This summary of 510(k) safety and effectiveness information is being
submitted in accordance with the requirement of SMDA and 21 CFR
807.92.
3.0 Classification
5- I
KD-512 and KD-712 Fully Automatic Electronic Blood Pressure Monitor FDA 510(k) Files
)C IO2P
KD-512 Fully Automatic Electronic Blood Pressure Monitor are for use by
medical professionals or at home and is a non-invasive blood pressure
measurement system intended to measure the diastolic and systolic blood
pressures and pulse rate of an adult individual by using a non-invasive
technique in which an inflatable cuff is wrapped around the upper arm. The
cuff circumference is limited to 22cm-48cm.
KD-512 Fully Automatic Electronic Blood Pressure Monitor are for use by
medical professionals or at home and is a non-invasive blood pressure
measurement system intended to measure the diastolic and systolic blood
pressures and pulse rate of an adult individual by using a non-invasive
technique in which an inflatable cuff is wrapped around the upper arm. The
cuff circumference is limited to 22cm-48cm.
The intended use and the indication for use of KD-512, as described in the
5- 2
KD-5l2 and KD-712 Fully Automatic Electronic Blood Pressure Monitor FDA5iO(k) Files
iI o)zcr-~a
labeling are the same as their predicated device KD-556. While the
intended use and the indication for use of KD-712 is the same as its
predicated devices KID-735.
5- 3
KD-5 12 and KD-7 12 Fully Automatic Electronic Blood Pressure Monitor FDA 510(k) Files
KD-512 is very similar with its predicate device in the intended use, the design
principle, the material, the performance and the applicable standards. Only
their appearance, the memory time, the display information and the averaging
measurement function are different.
KD-712 is very similar with the predicate device KD-738 in the intended use,
the design principle, the material, the performance and the applicable
standards. Only their appearance, the memory time and the display
information are different.
However, the test in this submission provides demonstration that these small
differences do not raise any new questions of safety and effectiveness to the
new devices.
5. 4
DEPARTMENT OF HEALTH & HUMAN SERVICES Publ IcHealth Ser vice
Re: K 102930
Trade/Device Name: Fully Automatic Electronic Blood Pressure Monitor, Models: KD-5 12,
KD-712
Regulation Number: 21 CFR 870.1130
Regulation Name: Non-Invasive Blood Pressure Measurement System
Regulatory Class: Class II
Product Code: DXN
Dated: Not Dated
Received: October 4, 201 0
We have reviewed your Section 5 10(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. Please note: CDRH does not evaluate information related to contract liability
warranties. We remind y'ou, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class Ill (PMA), it
may be subject to additional controls. Existing major regulations affecting your device can be
found in the Code of Federal Regulations, Title 21, Parts 800 to 898. Jn addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
Page 2 - Mr. Liui Yi
comply wvith all the Act's requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
device-related adverse events) (21 CFR 803); good mtanufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 53 1-542 of the Act); 21 CFR 1000- 1050.
If you desire specific advice for your device on our labeling regulation (21 CER Part 801), please
go to http://www~N.fda.gov/AboutFDA/CenitersOffices/CD R.lIC DRI-IOffitces/ucnm 115 809.htm for
the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please
note the regulation entitled, "Misbranding by reference to preimarket notification" (2ICFR Part
807.97). For questions regarding the reporting of adverse events under the MDR regulation (21
CER Part 803), please go to
http://www.fda. gov/MedicalDevices/Safetv/ReportaProblem/default.htm for the CDRH's Office
of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the
Division of Small Manufacturers, International and Consumer Assistance at its toll-free number
(800) 638-2041 or (301) 796-71 00 or at its Internet address
hittp://www.fda. pov/MedicalDevices/ResourcesforYou/Industrv/defauilt.htm.
Sincerely yours
Enclosure
KD-512 and KD-712 Fully Automatic Electronic Blood Pressure Monitor FDA 510(k) Files
KD-512 Fully Automatic Electronic Blood Pressure Monitor are for use by
medical professionals or at home and is a non-invasive blood pressure
measurement system intended to measure the diastolic and systolic blood
pressures and pulse rate of an adult individual by using a non-invasive
technique in which an inflatable cuff is wrapped around the upper arm. The
cuff circumference is limited to 22cm-48cm.
(Division Sign-Oft)g o
Division of Cardiovascular DevicesPaeIoI
510(k) Number________
4-1